Capstan Medical’s Platform is designed to treat mitral and tricuspid valve disease through a catheter while the heart is still beating.
Our cutting-edge solution combines advancements in surgical robotics with a catheter-based approach and provides a less invasive alternative to open heart surgery. The Capstan Platform will enable improved patient outcomes and shorter recovery times.
With a dedicated team of heart valve device experts and robotics engineers, we are fully committed to developing a comprehensive and transformative solution that will positively impact the lives of patients affected by these conditions.